Hypermethylation was shown to cause the downregulation of HOXB13 and worsen clinical outcome, consistent with the conclusions of Ghoshal in CRC.26 Our results further suggest that the HOXB13 methylation is regulated by DNMT3B in only RCC. This evidence concerns the gene DNMT3B and renal cell carcinoma.